TWD
TVRD

True Wealth Design’s Tvardi Therapeutics TVRD Stock Holding History

True Wealth Design’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4 Sell
2
-7
-78% -$22 ﹤0.01% 2654
2026
Q1 		$29 Buy
+9
New +$35 ﹤0.01% 2615

Other funds holding TVRD

GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
LI
LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

True Wealth Design's TVRD Position: Q2 2026 in Review

True Wealth Design reduced its Tvardi Therapeutics (TVRD) stake by 78% in Q2 2026, selling an estimated $22 and leaving 2 shares worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #2654.

True Wealth Design first reported a position in TVRD in Q1 2026 and has held it in 2 quarters since. The position peaked at $29 in Q1 2026. 4 funds tracked by Wall St. Rank hold TVRD as of Q2 2026.

  • True Wealth Design held 2 shares of Tvardi Therapeutics worth $4 as of Q2 2026.
  • True Wealth Design sold 7 Tvardi Therapeutics shares in Q2 2026, an estimated $22.
  • Tvardi Therapeutics made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #2654 holding.
  • True Wealth Design first reported a position in Tvardi Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • True Wealth Design's Tvardi Therapeutics position peaked at $29 in Q1 2026.
  • 4 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.